These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31317206)

  • 1. Chondromodulin-1 in health, osteoarthritis, cancer, and heart disease.
    Zhu S; Qiu H; Bennett S; Kuek V; Rosen V; Xu H; Xu J
    Cell Mol Life Sci; 2019 Nov; 76(22):4493-4502. PubMed ID: 31317206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chondromodulin-1 ameliorates osteoarthritis progression by inhibiting HIF-2α activity.
    Zhang X; Prasadam I; Fang W; Crawford R; Xiao Y
    Osteoarthritis Cartilage; 2016 Nov; 24(11):1970-1980. PubMed ID: 27321194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chondromodulin 1 stabilizes the chondrocyte phenotype and inhibits endochondral ossification of porcine cartilage repair tissue.
    Klinger P; Surmann-Schmitt C; Brem M; Swoboda B; Distler JH; Carl HD; von der Mark K; Hennig FF; Gelse K
    Arthritis Rheum; 2011 Sep; 63(9):2721-31. PubMed ID: 21391200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the cartilage derived anti-angiogenic factor chondromodulin-I decreases in the early stage of experimental osteoarthritis.
    Hayami T; Funaki H; Yaoeda K; Mitui K; Yamagiwa H; Tokunaga K; Hatano H; Kondo J; Hiraki Y; Yamamoto T; Duong LT; Endo N
    J Rheumatol; 2003 Oct; 30(10):2207-17. PubMed ID: 14528519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cartilage-specific matrix protein, chondromodulin-I (ChM-I), is a strong angio-inhibitor in endochondral ossification of human neonatal vertebral tissues in vivo: relationship with angiogenic factors in the cartilage.
    Kusafuka K; Hiraki Y; Shukunami C; Kayano T; Takemura T
    Acta Histochem; 2002; 104(2):167-75. PubMed ID: 12086337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Narrative Review of the Roles of Chondromodulin-I (Cnmd) in Adult Cartilage Tissue.
    Reyes Alcaraz V; Pattappa G; Miura S; Angele P; Blunk T; Rudert M; Hiraki Y; Shukunami C; Docheva D
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of Chm-I knockout on ectopic cartilage regeneration and homeostasis maintenance.
    Zhu Y; Zhang Y; Liu Y; Tao R; Xia H; Zheng R; Shi Y; Tang S; Zhang W; Liu W; Cao Y; Zhou G
    Tissue Eng Part A; 2015 Feb; 21(3-4):782-92. PubMed ID: 25251892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cartilage-derived anti-angiogenic factor, chondromodulin-I, during endochondral bone formation.
    Shukunami C; Hiraki Y
    Osteoarthritis Cartilage; 2001; 9 Suppl A():S91-101. PubMed ID: 11680695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valvular chondromodulin-1 expression is downregulated in a rabbit model of infective endocarditis.
    Grammer JB; Eichinger WB; Bleiziffer S; Benz MR; Lange R; Bauernschmitt R
    J Heart Valve Dis; 2007 Nov; 16(6):623-30; discussion 630. PubMed ID: 18095511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The N-terminal cleavage of chondromodulin-I in growth-plate cartilage at the hypertrophic and calcified zones during bone development.
    Miura S; Kondo J; Takimoto A; Sano-Takai H; Guo L; Shukunami C; Tanaka H; Hiraki Y
    PLoS One; 2014; 9(4):e94239. PubMed ID: 24710035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chondromodulin-I as a novel cartilage-specific growth-modulating factor.
    Hiraki Y; Shukunami C
    Pediatr Nephrol; 2000 Jul; 14(7):602-5. PubMed ID: 10912526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chondromodulin-I and tenomodulin: the negative control of angiogenesis in connective tissue.
    Shukunami C; Hiraki Y
    Curr Pharm Des; 2007; 13(20):2101-12. PubMed ID: 17627542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chondromodulin-I and tenomodulin are differentially expressed in the avascular mesenchyme during mouse and chick development.
    Shukunami C; Takimoto A; Miura S; Nishizaki Y; Hiraki Y
    Cell Tissue Res; 2008 Apr; 332(1):111-22. PubMed ID: 18239943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone modifiers, YY1 and p300, regulate the expression of cartilage-specific gene, chondromodulin-I, in mesenchymal stem cells.
    Aoyama T; Okamoto T; Fukiage K; Otsuka S; Furu M; Ito K; Jin Y; Ueda M; Nagayama S; Nakayama T; Nakamura T; Toguchida J
    J Biol Chem; 2010 Sep; 285(39):29842-50. PubMed ID: 20663886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic organization of the human chondromodulin-1 gene containing a promoter region that confers the expression of reporter gene in chondrogenic ATDC5 cells.
    Yanagihara I; Yamagata M; Sakai N; Shukunami C; Kurahashi H; Yamazaki M; Michigami T; Hiraki Y; Ozono K
    J Bone Miner Res; 2000 Mar; 15(3):421-9. PubMed ID: 10750556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chondrogenic differentiation of ChM-I gene transfected rat bone marrow-derived mesenchymal stem cells on 3-dimensional poly (L-lactic acid) scaffold for cartilage engineering.
    Xing SC; Liu Y; Feng Y; Jiang C; Hu YQ; Sun W; Wang XH; Wei ZY; Qi M; Liu J; Zhai LJ; Wang ZQ
    Cell Biol Int; 2015 Mar; 39(3):300-9. PubMed ID: 25319137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation in the core-promoter region of the chondromodulin-I gene determines the cell-specific expression by regulating the binding of transcriptional activator Sp3.
    Aoyama T; Okamoto T; Nagayama S; Nishijo K; Ishibe T; Yasura K; Nakayama T; Nakamura T; Toguchida J
    J Biol Chem; 2004 Jul; 279(27):28789-97. PubMed ID: 15107420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis inhibitors localized in hypovascular mesenchymal tissues: chondromodulin-I and tenomodulin.
    Hiraki Y; Shukunami C
    Connect Tissue Res; 2005; 46(1):3-11. PubMed ID: 16019413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of T cell responses by chondromodulin I, a cartilage-derived angiogenesis inhibitory factor: therapeutic potential in rheumatoid arthritis.
    Setoguchi K; Misaki Y; Kawahata K; Shimada K; Juji T; Tanaka S; Oda H; Shukunami C; Nishizaki Y; Hiraki Y; Yamamoto K
    Arthritis Rheum; 2004 Mar; 50(3):828-39. PubMed ID: 15022325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chondromodulin I is dispensable during enchondral ossification and eye development.
    Brandau O; Aszódi A; Hunziker EB; Neame PJ; Vestweber D; Fässler R
    Mol Cell Biol; 2002 Sep; 22(18):6627-35. PubMed ID: 12192060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.